Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients

Last 30 days: 50 accesses
Last 365 days: 621 accesses
All time: 2235 accesses

Michel de Bandt^*, Bruno Fautrel, Jean F Maillefert, Jean M Berthelot, Bernard Combe, René-Marc Flipo, Frédéric Lioté, Olivier Meyer, Alain Saraux, Daniel Wendling, Xavier Le Loët, Francis Guillemin and the STPR group of the French Society of Rheumatology